Views & Analysis A world leader in genomics, but England’s patients face obst... England is at the forefront of the genomics revolution – but NHS patients are unlikely to be the first to benefit.
News Health firms should prepare for Amazon move, says J&J chief Johnson & Johnson’s CEO Alex Gorsky says he would welcome the disruptive influence of Amazon should it decide to move into healthcare.
News A Pfizer consumer buyout won't detract from pharma business,... Walmsley has axed 40% of management team in shake-up
News Bad week for dementia R&D after Axovant howler and another f... Axovant misreports trial results, Lundbeck Alzheimer's drug fails
News AZ, Daiichi get Datroway nod in lung cancer on second try AZ and Daiichi Sankyo have claimed FDA approval for Datroway in lung cancer after switching indications for the TROP2-directed drug.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
